Volume 12 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
Lian Qiaoyan, Chen Ao, Xu Xin, et al. Analysis on dynamic changes of T lymphocyte subsets in recipients with stable graft status after lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 83-89. doi: 10.3969/j.issn.1674-7445.2021.01.013
Citation: Lian Qiaoyan, Chen Ao, Xu Xin, et al. Analysis on dynamic changes of T lymphocyte subsets in recipients with stable graft status after lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 83-89. doi: 10.3969/j.issn.1674-7445.2021.01.013

Analysis on dynamic changes of T lymphocyte subsets in recipients with stable graft status after lung transplantation

doi: 10.3969/j.issn.1674-7445.2021.01.013
More Information
  • Corresponding author: Ju Chunrong, E-mail:juchunrong@126.com
  • Received Date: 2020-09-06
    Available Online: 2021-01-19
  • Publish Date: 2021-01-19
  •   Objective  To analyze the dynamic changes and the influencing factors of T lymphocyte subsets in recipients with stable graft status within 1 year after lung transplantation.  Methods  Clinical data of 41 recipients with stable graft status after allogeneic lung transplantation were analyzed. The absolute value and ratio of T lymphocyte subsets in peripheral blood from recipients were measured by flow cytometry before operation, 2 weeks and each month (within 1 year) after operation, respectively. The effects of age, gender, body mass index (BMI), surgical method, incidence of primary graft dysfunction (PGD) after operation, and primary disease upon the absolute values of T lymphocytes were evaluated.  Results  Within 1 year after lung transplantation, the absolute values of CD3+, CD3+CD4+, CD3+CD8+T lymphocytes and CD4+/CD8+ ratio were changed over time (all P < 0.001). Compared with preoperative values, there was no statistical significance in the absolute values of CD3+ and CD3+CD4+T lymphocytes at 12 months after operation (P=0.659, 0.109), whereas the absolute value of CD3+CD8+T lymphocytes was increased (P=0.02) and the CD4+/CD8+ ratio was decreased (P < 0.001). Age, gender, BMI, surgical method and incidence of PGD after operation exerted no significant effect on the dynamic changes of absolute values of CD3+CD4+ and CD3+CD8+T lymphocytes (all P > 0.05). Primary disease before lung transplantation exerted no effect on the changes of CD3+CD4+T lymphocytes, whereas the postoperative absolute value of CD3+CD8+T lymphocytes was higher in recipients with infectious lung diseases (P < 0.05).  Conclusions  The absolute values of CD3+, CD3+CD4+, CD3+CD8+T lymphocytes in recipients with stable graft status after lung transplantation are relatively low in the early stage after lung transplantation, then gradually restore, and stabilize at 6 months after operation. Dynamic changes are not associated with age, gender, BMI, surgical method and incidence of PGD after operation of recipients.

     

  • loading
  • [1]
    HSIAO HM, SCOZZI D, GAUTHIER JM, et al. Mechanisms of graft rejection after lung transplantation[J]. Curr Opin Organ Transplant, 2017, 22(1):29-35. DOI: 10.1097/MOT.0000000000000371.
    [2]
    练巧燕, 陈奥, 巨春蓉.肺移植术后T细胞亚群研究进展[J/CD].中华移植杂志(电子版), 2019, 13(2): 151-155. DOI: 10.3877/cma.j.issn.1674-3903.2019.02.016.

    LIAN QY, CHEN A, JU CR. Progress on T lymphocyte subsets after lung transplantation[J/CD]. Chin J Transplant (Electr Vers), 2019, 13(2): 151-155. DOI: 10.3877/cma.j.issn.1674-3903.2019.02.016.
    [3]
    CALAROTA SA, CHIESA A, DE SILVESTRI A, et al. T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation[J]. J Clin Virol, 2015, 69:110-116. DOI: 10.1016/j.jcv.2015.06.078.
    [4]
    SNELL GI, YUSEN RD, WEILL D, et al. Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading-a 2016 consensus group statement of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2017, 36(10):1097-1103. DOI: 10.1016/j.healun.2017.07.021.
    [5]
    COSIMI AB, COLVIN RB, BURTON RC, et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts[J]. N Engl J Med, 1981, 305(6):308-314. DOI: 10.1056/NEJM198108063050603.
    [6]
    YAMADA Y, BRÜSTLE K, JUNGRAITHMAYR W. T helper cell subsets in experimental lung allograft rejection[J]. J Surg Res, 2019, 233:74-81. DOI: 10.1016/j.jss.2018.07.073.
    [7]
    LIU Z, FAN H, JIANG S. CD4(+) T-cell subsets in transplantation[J]. Immunol Rev, 2013, 252(1):183-191. DOI: 10.1111/imr.12038.
    [8]
    马锡慧, 高钰, 韩永, 等.流式细胞术在肾移植术后感染中的诊断价值[J].器官移植, 2018, 9(2):137-141, 155. DOI: 10.3969/j.issn.1674-7445.2018.02.008.

    MA XH, GAO Y, HAN Y, et al. Diagnostic value of flow cytometry in postoperative infection after renal transplantation[J]. Organ Transplant, 2018, 9(2):137-141, 155. DOI: 10.3969/j.issn.1674-7445.2018.02.008.
    [9]
    CALAROTA SA, ZELINI P, DE SILVESTRI A, et al. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients[J]. Transplantation, 2012, 93(1):112-119. DOI: 10.1097/TP.0b013e318239e90c.
    [10]
    GARDINER BJ, NIERENBERG NE, CHOW JK, et al. Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients[J]. Clin Infect Dis, 2018, 67(9):1395-1402. DOI: 10.1093/cid/ciy295.
    [11]
    IOVINO L, TADDEI R, BINDI ML, et al. Clinical use of an immune monitoring panel in liver transplant recipients: a prospective, observational study[J]. Transpl Immunol, 2019, 52:45-52. DOI: 10.1016/j.trim.2018.11.001.
    [12]
    LEE SD, KIM SH, KONG SY, et al. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab[J]. Transpl Immunol, 2015, 32(1):29-34. DOI: 10.1016/j.trim.2014.11.216.
    [13]
    SHAH RJ, DIAMOND JM. Update in chronic lung allograft dysfunction[J]. Clin Chest Med, 2017, 38(4):677-692. DOI: 10.1016/j.ccm.2017.07.009.
    [14]
    KUMAR R, ISON MG. Opportunistic infections in transplant patients[J]. Infect Dis Clin North Am, 2019, 33(4):1143-1157. DOI: 10.1016/j.idc.2019.05.008.
    [15]
    纪勇, 陈静瑜, 郑明峰, 等.肺移植术后早期原发性移植物失功的危险因素与防治[J].中华胸心血管外科杂志, 2017, 33(12):738-742. DOI: 10.3760/cma.j.issn. 1001-4497.2017.12.009.

    JI Y, CHEN JY, ZHENG MF, et al. Clinical analysis of risk factors for early primary graft dysfunction after lung transplantation[J]. Chin J Thorac Cardiovasc Surg, 2017, 33(12):738-742. DOI: 10.3760/cma.j.issn.1001-4497.2017.12.009.
    [16]
    钟元, 孟礼飞, 杨旭晖, 等.肺移植免疫抑制剂的应用进展[J].临床肺科杂志, 2019, 24(11):2075-2078. DOI: 10.3969/j.issn.1009-6663.2019.11.031.

    ZHONG Y, MENG LF, YANG XH, et al, Progress on the application of immunosuppressant in lung transplantation[J]. J Clin Pulm Med, 2019, 24(11):2075-2078. DOI: 10.3969/j.issn.1009-6663.2019.11.031.
    [17]
    SHTRAICHMAN O, AHYA VN. Malignancy after lung transplantation[J]. Ann Transl Med, 2020, 8(6):416. DOI: 10.21037/atm.2020.02.126.
    [18]
    ZAFFIRI L, LONG A, NEELY ML, et al. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: analysis of ISHLT registry[J]. J Heart Lung Transplant, 2020, 39(10):1089-1099. DOI: 10.1016/j.healun.2020.06.010.
    [19]
    CHAMBERS DC, CHERIKH WS, HARHAY MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10):1042-1055. DOI: 10.1016/j.healun.2019.08.001.
    [20]
    COIFFARD B, PELARDY M, GOMEZ C, et al. Kinetics of peripheral blood lymphocyte subsets in lung transplant recipients[J]. J Heart Lung Transplant, 2015, 34(4):S260. DOI: 10.1016/j.healun.2015.01.724.
    [21]
    COIFFARD B, PELARDY M, LOUNDOU AD, et al. Effect of immunosuppression on target blood immune cells within 1 year after lung transplantation: influence of age on T lymphocytes[J]. Ann Transplant, 2018, 23:11-24. DOI: 10.12659/aot.906372.
    [22]
    NOSOTTI M, TARSIA P, MORLACCHI LC. Infections after lung transplantation[J]. J Thorac Dis, 2018, 10(6):3849-3868. DOI: 10.21037/jtd.2018.05.204.
    [23]
    HODGE G, HODGE S, YEO A, et al. BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-like, and NK cells in the small airways[J]. Transplantation, 2017, 101(10):2469-2476. DOI: 10.1097/TP.0000000000001592.
    [24]
    HARPER SJ, ALI JM, WLODEK E, et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection[J]. Proc Natl Acad Sci U S A, 2015, 112(41):12788-12793. DOI: 10.1073/pnas.1513533112.
    [25]
    YAP M, BROUARD S, PECQUEUR C, et al. Targeting CD8 T-cell metabolism in transplantation[J]. Front Immunol, 2015, 6:547. DOI: 10.3389/fimmu.2015.00547.
    [26]
    COIFFARD B, PILONI D, BOUCEKINE M, et al. Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: a multicenter international study[J]. Transpl Immunol, 2018, 48:47-54. DOI: 10.1016/j.trim.2018.02.013.
    [27]
    GAUTHIER JM, LI W, HSIAO HM, et al. Mechanisms of graft rejection and immune regulation after lung transplant[J]. Ann Am Thorac Soc, 2017, 14(Suppl 3):S216-S219. DOI: 10.1513/AnnalsATS.201607-576MG.
    [28]
    AHYA VN, DIAMOND JM. Lung transplantation[J]. Med Clin North Am, 2019, 103(3):425-433. DOI: 10.1016/j.mcna.2018.12.003.
    [29]
    YOUNG KA, DILLING DF. The future of lung transplantation[J]. Chest, 2019, 155(3):465-473. DOI: 10.1016/j.chest.2018.08.1036.
    [30]
    HACHEM RR. Acute rejection and antibody-mediated rejection in lung transplantation[J]. Clin Chest Med, 2017, 38(4):667-675. DOI: 10.1016/j.ccm.2017.07.008.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Article Metrics

    Article views (276) PDF downloads(33) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return